A patient presenting with symptomatic hypomagnesemia caused by metformin-induced diarrhoea: a case report

INTRODUCTION: Metformin is licensed for treatment of diabetes mellitus type 2. This report describes a patient on metformin who developed diarrhoea and symptomatic hypomagnesemia. To the author's knowledge, this is the first report on metformin-induced symptomatic hypomagnesemia. CASE PRESENTAT...

Descripción completa

Detalles Bibliográficos
Autor principal: Svare, Anders
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783112/
https://www.ncbi.nlm.nih.gov/pubmed/19946527
http://dx.doi.org/10.1186/1757-1626-2-156
Descripción
Sumario:INTRODUCTION: Metformin is licensed for treatment of diabetes mellitus type 2. This report describes a patient on metformin who developed diarrhoea and symptomatic hypomagnesemia. To the author's knowledge, this is the first report on metformin-induced symptomatic hypomagnesemia. CASE PRESENTATION: The patient was a 57-year old Caucasian male with diabetes mellitus type 2. He had been on metformin for nine years and presented with chronic diarrhoea, spasms, paresthesias, pain, and malaise. Blood tests revealed hypomagnesemia, hypocalcemia, and hypokalemia. CONCLUSION: Drugs associated with diarrhoea may induce malabsorption. If malabsorption is substantial it may result in further symptoms of clinical importance. In some cases potentially life-threatening conditions may occur.

Ejemplares similares